GlassScriptPhysician profile
Nicole E Brown
NPI 1609120575
$5,270.85
in general payments reported to CMS, 2019-2025
25 companies · $1,346 in 2025
The $1,346 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $692 · 2022: $546 · 2023: $535 · 2024: $2,152 · 2025: $1,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,500 · Travel and Lodging: $1,533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,500.04 |
| Travel and Lodging | $1,532.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,180.17 | 2021-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Novartis Pharmaceuticals Corporation | $564.64 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $388.42 | 2021-2024 | Xarelto, Spravato |
| Boehringer Ingelheim Pharmaceuticals, INC. | $351.53 | 2021-2025 | Jardiance |
| Abbott Laboratories | $282.27 | 2023-2025 | Proclaim, Ensite Precision, Amplatzer Amulet |
| Astrazeneca Pharmaceuticals LP | $231.72 | 2021-2025 | Wainua |
| Bayer Healthcare Pharmaceuticals INC. | $222.47 | 2021-2025 | |
| Astellas Pharma US INC | $180.84 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.97 | 2021-2025 | Lifevest |
| Merck Sharp & Dohme LLC | $99.37 | 2025 | Verquvo, Capvaxive |
| Amgen INC. | $92.54 | 2021-2023 | Repatha |
| Atricure, INC. | $87.02 | 2021-2025 | Atriclip Laa Exclusion System |
| Lexicon Pharmaceuticals, INC. | $66.34 | 2023-2024 | Inpefa |
| Pfizer INC. | $60.41 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $58.79 | 2024-2025 | Camzyos, Eliquis |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $52.69 | 2022-2023 | Micra |
| Edwards Lifesciences Corporation | $50.03 | 2021-2025 | Sapien 3 Ultra Resilia |
| Irhythm Technologies, INC. | $45.93 | 2023 | Zio Xt Patch |
| Novo Nordisk INC | $42.25 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $23.81 | 2022 | |
| Amarin Pharma, INC. | $20.46 | 2021 | |
| Cardiva Medical, INC. | $19.55 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $15.80 | 2023 | Barostim Neo System |
| Bridgebio Pharma, INC. | $14.22 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $13.61 | 2025 | Onpattro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.